A Hub for Inventors
Primed for commercializing technology and bridging big ideas to the market
By The Numbers
UH maintains a strong intellectual property portfolio that continues to gain momentum every year. For several years now, UH has led the nation in royalty earnings among public universities without medical schools.
$59M Licensing Income FY20
Invention Disclosures FY20
U.S. Patents Issued FY20
NAI Fellows/Senior Members
|2022-005||Matrix metallopeptidase 8 promotes tumor infiltration and antitumor activity of CD19 CAR T cells||Provided herein are compositions containing genetically modified immune cells that express a ECM degrading enzyme, such as a matrix metallopeptidase. Overexpression of mature matrix metallopeptidase improves the tumor infiltrating capabilities of immunotherapeutic agents against solid tumors…|
|2022-007||A salicylic acid-inducible gene expression system for mammalian cells||Ligand inducible proteins that enable precise and reversible control of nuclear translocation ofpassenger proteins have broad applications ranging from genetic studies in mammals to therapeutics that target diseases such as cancer and diabetes. One of the drawbacks of the current translocation…|
|2022-010||Strategy for Synthesizing Nano-sized Zeolites using Germanium Oxide||This invention establishes an approach to prepare nano-sized zeolites using germanium oxide (GeO2) as a component of the overall synthesis composition. Zeolites are nanoporous crystalline materials that exhibit internal diffusion limitations to guest molecules, which often compromises their…|
|2022-011||Laser-Driven Micro-fluidic Pump for Liquid Mixing on Bio Chips||An apparatus for controlling a cylinder by a microfluidic stream includes a microtube, a first laser-driven photoacoustic microfluid pump (LDMP), and a fiber optic element. The microtube includes a fluid and a cylinder. The fiber optic element includes a first end and a second end. The first end is…|
|2022-013||Targeting H19X-encoded non-coding RNAs to treat muscle wasting, cachexia, sarcopenia and heart failure||Provided here are compositions and methods of preventing or treating a muscle disorder in a subject, such as muscle wasting, cachexia, sarcopenia and heart failure. The compositions include inhibitors targeting one or more of the H19X-encoded non-coding RNAs. The inhibitors can inhibit expression…|
|2022-014||Ultra-sensitive VFA-based rapid detection of Interleukin 6 for inflammation||Provided herein is vertical flow immunoassay devices for detecting presence or an amount of cytokines, e.g., interleukin 6 (IL-6) in a sample. Also provided herein are immunoassay methods for detecting presence or an amount of cytokines, e.g., IL-6 in a sample, using a vertical flow immunoassay…|
Check Out Plant-Based Polymers
New plant-based material discovered at UH could replace today's petroleum-based plastics.
University of Houston has developed breakthroughs in several therapeutic indications that have transformed patient lives around the world. UH is continuing to establish several key partnerships with the biopharma industry to push lab discoveries to the market. The status of these therapeutics is in pipeline can be explored below.